NC 111585
Alternative Names: NNC 111585Latest Information Update: 24 Jun 2003
At a glance
- Originator Novo Nordisk
- Class
- Mechanism of Action Muscarinic M1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 06 Dec 2000 New profile
- 06 Dec 2000 Preclinical development for Alzheimer's disease in Denmark (Unknown route)